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We have utilized active immunization against growth hormone releasing factor 
(GRF) to investigate relationships among somatotropin (ST), insulin-like growth 
factor-I (IGF-r), IGF binding proteins (IGFBP) and ovarian function in heifers. 
Active immunization against GRF (GRFi) has been demonstrated to abolish 
episodic release of ST and decrease serum concentrations of IGF-I. In initial 
experiments investigating onset of puberty, breeds of heifers differing in growth rate 
and reproductive traits (Angus, Charolais and Simmental) were immunized against 
GRF or served as controls (immunized against carrier protein, human serum 
albumin, HSAi). GRFi decreased rate of muscle and skeletal growth, but increased 
deposition of adipose tissue. In Angus and Charolais, but not Simmental heifers, 
GRFi at 6 mo of age significantly delayed onset of puberty beyond 18 mo of age. 
Retrospective analyses of serum IGF-I revealed that GRFi heifers reaching puberty 
at a normal age had greater pre-treatment (6 mo of age) IGF-I tha1J. GRFi heifers in 
which puberty was delayed. Collectively, these results strongly indicate that the 
bovine hypothalamic-hypophyseal-ovarian axis is particularly sensitive to changes in 
metabolism at or near 6 mo of age. 
Another series of experiments tested the hypothesis that lowering serum IGF-I 
via GRFi initially at 3 mo of age would increase the percentage of Angus 
and Simmental heifers not reaching puberty. Three mo old Angus and Simmental 
heifers were assigned to GRFi (n = 18), HSAi (n = 14) or received no treatment 
(controls, n = 16). HSAi and GRFi heifers were unilaterally ovariectomized 
(ULO) at 6 mo of age. As anticipated, GRFi at a younger age increased percentage 
of heifers not reaching puberty; over 75% of control and HSAi heifers reached 
puberty by 14 mo.of age compared to 22% of GRFi heifers. Serum and follicular 
fluid (FFL; follicles :::;4 mm) concentrations of JGF-J were suppressed by GRFi. 
Serum, but not FFL concentrations of IGF binding protein-2 (IGFBP-2) were 
greater in GRFi than in HSAi heifers. GRFi delayed puberty apparently by 
suppressing follicular growth because number of fol1icles :::; 7 mm was significantly 
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lower in GRFi than in HSAi heifers. In conclusion, active immunization against 
GRF at 3 or 6 months of age delays puberty in beef heifers. Delayed puberty was 
preceded by suppression of follicular growth, and decreased concentrations of IGF-I 
in serum and follicular fluid. Collectively, these studies demonstrate that ovarian 
function between 3 and 8 mo of age and subsequent onset of puberty are particularly 
sensitive to changes in the ST-IGf-I axis. 
Key w 0 r d s: heifer, IGF-I, GRF immunization, follicle, IGF binding proteins, puberty 
INTRODUCTION 
Lifetime productivity of beef femal~s is enhanced if heifers conceive at 13 
mo of age (1). Several factors such as breed, nutritional status, and exposure to 
bulls influence timing of puberty (2). Of most practical importance is the effect 
of nutritional status. Restriction of feed intake, either experimentally- or 
environmentally-induced, delays puberty in heifers (2,3). A better 
understanding of mechanisms through which alterations in metabolism affect 
ovarian function and ultimately puberty could lead to management practices 
that would increase overall productivity. 
Changes in the hypothalamo-hypophyseal-ovarian axis prior to puberty 
have been previously reported (2,3). Puberty in heifers is preceded by an 
increase in frequency of episodic release of luteinizing hormone (LH), 
presumably due to a decrease in negative feedback of estradiol on LH (4-7). 
The anterior pituitary and ovary are responsive to gonadotropin releasing 
hormone (GnRH) and gonadotropins, respectively, as early as 3 months of age 
(8-11). However, induction of follicular growth and ovulation in prepuberal 
heifers is typically not followed by normal estrous cycles (9). Thus, changes in 
the hypothalamus, particularly sensitivity to negative feedback effects of 
estradiol and alterations in frequency of GnRH release, are prerequisite for 
normal timing of puberty in the heifer. 
Several researchers have demonstrated that feed restriction affects ovarian 
function through a decrease in frequency of LH release (12-14). Potential 
signals mediating effects of a nutritional stress on ovarian function have been 
the subject of several reviews (13-16). However, precise signals through which 
alterations in metabolism affect hypothalamo-hypophyseal-ovarian function 
have not been elucidated. Experiments conducted in several species have 
demonstrated that restriction of feed intake elicits changes in metabolic 
hormones and metabolites. For example, concentrations of non-esterified fatty 
acids increase and insulin decrease (12, 17,18) during feed restriction. In 
addition, feed restriction alters the ST, IGF-I and IGFBP axis (19-21). The 
normal positive relationship between ST and IGF-I is "uncoupled" by 
restriction of feed intake; concentrations of ST increase and IGF-I decrease 
after feed restriction in ruminants (22-24). Decreased serum IGF-I and 
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decreased responsiveness of IGF-I to ST are temporally related to a reduction 
in hepatic ST receptors (25). Studies have demonstrated that feed restriction 
causes a decrease in hepatic concentration of IGF-I mRNA (26,27); however, 
restriction of protein intake may alter stability of 7.5-kb IGF-I mRNA (28). 
In addition to "uncoupling" ST and IGF-I, feed restriction causes shifts in 
abundance of serum IGFBP (19-21). In particular IGFBP-l has also been 
demonstrated to be involved in plasma glucose regulation (29,30). Evidence for 
metabolic regulation of IGFBP has also been demonstrated using the diabetic 
pig model. Diabetes causes a decrease in serum IGF-I (31) and a decrease in 
a 29 kDa IGFBP (32). More recently, Hughey et al. found that FFL from 
diabetic pig follicles had lower IGFBP activity than non-diabetic pig follicles 
(33). Less data is available for effects of nutrition on IGFBP in ruminants (21). 
One report found that feed restriction in sheep was associated with a decrease 
in serum IGFBP-3 (34). 
Much information is available with regard to effects of IGF-I and IGFBP 
on ovarian function in vitro. Several reports have demonstrated effects of 
IGF-I and IGFBP on granulosa cell differentiation and proliferation (35-37). 
In vitro, IGF-I enhances FSH-stimulated steroid production in murine (35) 
and porcine (36,37) granulosa cells. Addition of FSH increases IGF-I (36) and 
decreases IGFBP secretion (37,38) by porcine granulosa cells. IGFBP may 
serve as additional regulators of FSH-stimulated steroid production by 
granulosa cells and follicular differentiation. Several IGFBP mRNA are found 
in rat (39) and pig (38,40) ovaries. In both rat (41) and pig (38) granulosa cell 
cultures, low doses stimulate and high doses of FSH inhibit IGFBP activity. 
Intra-ovarian IGFBP are further regulated by IGF-I. Grimes and Hammond 
(42) recently reported that IGF-I stimulated production of IGFBP-2 and -3 by 
porcine granulosa cells in vitro. 
Less information is available with regard to in vivo effects of IGF-I and ST 
on ovarian function. In vivo effects of ST on ovarian function have been 
studied in cattle (43-48) and gilts (49-53) and have yielded equivocal effects. 
More recent reports have demonstrated that ST via direct or indirect effects 
may alter folliculogenesis. Exogenous ST administered to lactating cows 
(54,55) or non-lactating heifers (44) increased number of medium sized 
follicles, whereas ST increased number of small follicles in gilts (53). In 
addition, in two separate reports ST increased serum progesterone (43,48); 
however, effects on LH and FSH were equivocal (43,48). A positive effect of 
ST and(or) IGF-I on follicular growth is consistent with reports in humans 
that concomitant administration of ST enhances effectiveness of 
gonadotropins for induction of ovulation (56). 
Putative mechanisms through which ST alter follicular growth include 
direct effects on the ovary, indirect via the hypothalamo-hypophyseal axis 
and(or) indirect through IGF-I at any or all of the aforementioned sites. Lucy 
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(57) reported that ST receptors are present in the bovine ovary, with 
concentrations of ST receptor mRNA and receptors greater in the CL than in 
follicles (57). Thus, ST may alter ovarian function via direct effects on the 
ovary with IGF-I likely acting as an intra-ovarian mediator. However, an 
endocrine effect of IGF-I cannot be excluded (58,59). 
In addition to IGF-I receptors and mRNA present in the ovary (35,36) and 
liver (26), IGF-I mRNA and receptors are present in the median eminence 
(60-62). A recent report adds credence to possible endocrine effects of IGF-I; 
in vitro release of GnRH by rat median eminence was increased by IGF-I (63). 
Both IGF-Il and insulin were effective but at greater concentrations. 
The GRF-ST-IGF-I axis could also affect ovarian function via direct 
effects of peripherally or locally produced GRF. Spicer and Enright (64) found 
that exogenous GRF altered number of medium follicles in heifers. Several 
reports have demonstrated that G RF affects granulosa cell function in vitro 
(65-67)~ Finally, GRF mRNA is present in the rat ovary (68). Further studies 
are needed to clarify mechanisms through which alterations in GRF-ST-IGF-I 
alter ovarian function. 
Based on the aforementioned effects of ST and IGF-I on ovarian function 
in vitro and in vivo, we felt it was particularly important to develop an 
in vivo model in which we could alter peripheral and tissue ST and IGF-I 
concentrations. For our model we have utilized active immunization against 
GRF conjugated to human serum albumin (GRFi). GRFi effectively lowers 
serum ST by inhibiting episodic release from the anterior pituitary. 
Consequently, serum ST and IGF-I concentrations are greatly diminished 
but remain detectable. We have utilized GRFi to investigate relationships 
among metabolism, body composition and reproduction in porcine (69,70) 
and bovine (71,72) species under a variety of physiological states. The 
remainder of this paper will focus on our studies investigating relationships 
among ST, IGF-I, IGFBP, growth and puberty in heifers. 
Effect of GRFi on ST, IGF-l and IGFBP in serum 
In initial studies, we actively immunized gestating-lactating females (69,71) 
or postpuberal females (70) against GRF. GRFi abolished episodic release of 
ST in bovine (heifers and cows) and porcine females (gilts). In addition, serum 
concentrations of IGF-I were significantly decreased (70,71). More recently, 
we evaluated effects of GRFi on hormones and metabolites in heifers (72) and 
steers (73). Both frequency of release and mean ST were decreased by GRFi. 
Active immunization against GRF, in addition to producing the 
aforementioned effects on ST and IGF-I, alters other metabolites and 
hormones. Serum concentrations of insulin and to a lesser extent, glucose are 
consistently decreased by GRFi in heifers (72). In contrast, we have failed to 
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observe an effect of GRFi on serum NEFA. These changes in metabolism are 
consistent with previously reported effects of exogenous ST on insulin, glucose 
and body composition in cattle (74,75) and swine (76). In addition, we
previously reported that GRFi during gestation and lactation in pigs increased 
fat deposition in vivo and lipogenesis in vitro (77). Consistent with these results 
in swine, GRFi increased deposition of fat in heifers (72) and steers (78). 
Based on previous results (19,21), we hypothesized that GRFi and the 
resulting changes in ST and IGF-I would drastically alter profiles of serum 
IGFBP (i.e. - IGFBP-3 would decrease; IGFBP-2 would increase). As 
anticipated, serum concel1trations of IGFBP-3 were decreased by GRFi. This 
was likely due to decreased IGF-I and(or) ST (19,21). Serum concentrations 
(ng/ml) of IGFBP-2 were consistently greater in GRFi (594 + 48) than in 
HSAi (384+ 52) heifers (79). These effects on IGFBP-2 and -3 were reversed by 
administration of exogenous ST (79). These observations are consistent with 
previous reports by Cohick et al. (80) and others (21,81). Thus, GRFi provides 
an excellent model for altering concentrations of ST, IGF-I and IGFBP in vivo. 
Effect of GRFi on prepuberal ovarian function and puberty in heifers 
We reasoned that GRFi at an early age would alter growth rate and body 
composition and thus provide a model to investigate relationships among body 
composition, metabolism and onset of puberty in heifers. In our initial 
experiment (72), we evaluated effects of GRFi in two diverse genotypes (Angus 
and Charolais) differing in age at puberty, mature body weight and body 
composition. We actively immunized Angus and Charolais (n=43) heifers 
against GRF or HSA at 6 months of age. Boosters of appropriate antigen were 
given at 7.5 mo of age and at 2-3 mo intervals thereafter. GRFi decreased 
deposition of muscle and skeletal development; however, fat depth was 
increased. These changes were associated with decreased ST and IGF-I. Effects 
of GRFi on body composition, ST and IGF-I were similar in Angus and 
Charolais heifers (72). 
Our most exciting result was the effect of GRFi on puberty; GRFi delayed 
puberty beyond 18 mo in over 40% of heifers (Fig. 1) (72). In addition, 
treatment effects were similar in Angus and Charolais heifers. Differences in 
average concentrations or frequency of release of LH were not detected. As 
depicted in Fig. 1., effects of GRFi on puberty were an "all or none" 
phenomena, i.e. heifers reached puberty by 12-13 mo of age or they remained 
acyclic until at least 18 mo of age (82). We were therefore interested in 
ascertaining potential differences between heifers that cycled or remained 
acyclic. We found that serum concentrations of IGF-I at time of treatment 
(6 mo of age) and average daily gain from 6 to 8 mo of age were greater in 
GRFi heifers that reached puberty than in GRFi heifers that were acyclic at 18 
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mo of age (72). We were interested in determining whether antibody 
production differed in cyclic versus acyclic heifers. Percentage binding of 
125I_GRF one week after first booster was greater in acyclic than in cyclic 
Angus heifers; however, percentage binding was not related to occurrence of 
puberty in Charolais heifers (72). 
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Fig. 1. Cumulative percentage heifers attaining puberty from 8 to 19 mo of age in Angus and 
Charolais heifers immunized at 6 mo of age against HSA or GRF. Onset of puberty was similar in 
Angus and Charolais heifers thus data were pooled. Significantly fewer GRFi heifers reached 
puberty by 18 mo of age compared to controls (HSAi) (72). 
The "all or none" effect of GRFi on puberty has provided an excellent 
opportunity to evaluate effects of low serum IGF-I and ST on cycle length, 
serum progesterone and conception rates. Initially, we characterized 
concentrations of progesterone and IGF-I in cyclic, control (HSAi) and GRFi 
heifers. Serum samples were collected every other day via venipuncture from 
HSAi (n = 14) and GRFi (n = 9) heifers. Length of estrous cycle or luteal phase 
(based on serum progesterone) was not affected by GrFi. Furthermore, 
concentrations of progesterone were similar in GRFi and HSAi heifers. Serum 
IGF-I did not vary significantly with day of cycle in either HSAi or GRFi 
heifers. Finally, all heifers were exposed to bulls, conceived and calved. Thus, 
providing heifers attain puberty, GRFi did not alter progesterone, cycle length 
or ability of heifers to become pregnant and calve. 
Our next study evaluated the hypothesis that GRFi delays puberty 
independent of effects of GRFi on ADG (83). Angus, Charolais and 
Simmental heifers were assigned to GRFi or HSAi at 6 mo of age. At 7.5 mo 
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Fig. 2. Onset of puberty in GRFi and HSAi Simmental (S), Angus (A) and Charolais (c) heifers. 
Pubertal onset was not affected by GRFi or feed restriction in S heifers; therefore, data were 
pooled and represented as S (all). Feed restriction failed to alter timing of puberty in A and 
C heifers, thus data were pooled (HSAi A & C). Immunization against GRF delayed puberty in 
A and C, but not in S heifers (83). 
of age, HSAi heifers were fed to gain .9 (HSAi-C) or restricted in feed intake to 
gain .7 (HSAi-R) kg/d. GRFi heifers were fed to gain .9 kg/d with an expected 
gain of .7 kg/d. Puberty was monitored by weekly serum progesterone 
concentrations and frequent blood samples (every 15 min for 8 h) were 
collected at 3 wk intervals from 28 heifers. As anticipated , ADG and serum 
IGF-I were lower in GRFi and HSAi-R than in control heifers. However, 
concentrations of IGF-I were only marginally decreased by HSAi-R, 
particularly when compared to effects of GRFi. Further analyses revealed that 
serum LH was decreased by HSAi-R, but not by GRFi. Although feed 
restriction had marginal yet significant effects on IGF-I and LH, onset of 
puberty was not affected in Angus, Charolais and Simmental heifers. 
Consistent with our previous report, GRFi delayed puberty (P < .05) in Angus 
and Charolais heifers (Fig. 2). In contrast, percentage of heifers puberal by 15 
mo of age was similar in GRFi and control Simmental heifers (Fig. 2). These 
results indicated a breed difference in mechanism or timing of mechanism with 
regard to effects of IGF-I on prepuberal ovarian function. Collectively, these 
data indicate that GRFi results in greater reductions in IGF-I than feed 
restriction. In addition, absence of effects of GRFi on LH indicate a potential 
ovarian site of action. 
Based on previous results suggesting that onset of puberty in GRFi heifers 
was related to IGF-I at time of treatment (6 mo of age) (72) and GRFi at 6 mo 
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of age failed to delay puberty in Simmental heifers (83), we hypothesized that 
GRFi at an earlier age would delay puberty in a greater percentage of heifers. 
To test this hypothesis we assigned Angus and Simmental heifers to GRFi, 
HSAi or no treatment (Con) at 3 mo of age (84). In addition, we unilaterally 
ovariectomized (ULO; left ovary) GRFi and HSAi heifers at 6 mo of age in 
order to determine effects on follicular growth. Follicular diameters were 
recorded and follicular fluid asp~rated. As hypothesized, G RFi at 3 mo of age 
decreased percentage of heifers that reached puberty by 14 mo of age (Fig. 3). 
Onset of puberty was not significantly altered by ULO. In addition, GRFi 
delayed puberty in Angus and Simmental heifers. Thus, our failure to delay 
puberty in Simmental heifers via GRFi at 6 mo of age was due to a breed 
difference in timing of immunization. 
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Fig. 3. Attainment of puberty in heifers immunized against GRF or HSA at 3 mo of age, 
or heifers not treated. GRFi and HSAi heifers were unilaterally ovariectomized at 6 rno 
of age. Unilateral ovariectomy did not alter timing of puberty, thus data from control and 
HSAi heifers were pooled (Con). GRFi at 3 rno of age delayed puberty beyond 15 rno 
in over 75 % of heifers (84). 
Summarization of effects of GRFi at 3 mo of age on follicular growth and 
FFL concentrations of IGF-I and IGFBP at 6 mo of age provided valuable 
insight as to possible mechanisms through which GRFi delayed puberty (84). 
Number of large, but not small or medium sized follicles at 6 mo of age were 
decreased by GRFi (.3 +.2 vs 1.1 + .4). In addition, we found that serum and 
FFL :::;;4 mm follicles) concentrations of IGF-I were lower in GRFi than in 
HSAi heifers. In addition to lowering concentrations of IGF-I in both 
compartments, GRFi dramatically reversed the ratio of serum to FFL IGF-I 
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(HSAi - serum >FFL; GRFi - FFL > serum). In vitro reports have 
demonstrated that IGF-I is synthesized by granulosa cells (35,36); however, 
we do not know whether decreased FFL IGF-I reflects transudation of 
serum IGF-I and(or) reduction in ovarian synthesis of IGF-I. A shift in 
the ratio of serum to FFL IGF-I by GRFi provides indirect evidence 
for an ovarian site of action. 
Equally important to effects of GRFi on serum and FFL IGF-I is potential 
effects of GRFi on IGFBP. As anticipated (19), GRFi increased serum 
IGFBP-2 (84). In contrast toIGF-I, FFL (:::::; 4 mm follicles) concentrations of 
IGFBP-2 were not significantly effected by GRFi. However, apparent 
concentrations of FFL IGFBP-3 were decreased by GRFi. IGFBP-3 has been 
demonstrated in vitro to have inhibitory and stimulatory effects on IGF-I 
action (19). Most effects of IGFBP on IGF-I-mediated FSH action in ovarian 
cultures have been inhibitory (35,36,85,86). Consistent with this effect is the 
observation that diabetes increases follicular atresia (31) and 31 kDa IGFBP in 
swine (32,33). Future studies will be necessary to clearly define the role of 
IGFBP in mediating the effects of GRFi on puberty in heifers. 
Initial experiments have been conducted with the goal of stimulating 
preovulatory follicular growth and ovulation in acyclic, G RFi heifers. Acyclic, 
GRFi heifers were administered recombinant ST (sometribove) or vehicle daily 
for 56 days (82). Ultrasonography of follicles revealed that diameter of largest 
follicle was increased after 3 days of ST; however, a chronic effect on ovarian 
function was not detected. Future replacement therapies may need to be 
initiated at 3 to 6 mo of age to be effective. 
Collectively, these studies indicate that follicular growth between 3 and 
6 mo of age is particularly sensitive to alterations in serum and(or) ovarian 
IGF-I. In addition, we speculate that GRFi at 3 mo of age disrupts normal 
patterns of follicular growth. Waves or cycles of follicular growth have been 
reported for prepuberal heifers (87,88); therefore, GRFi may delay puberty by 
altering or blocking waves of follicular growth. 
Immuno-neutralization of GRF may decrease follicular growth through 
effects mediated at the ovary, pituitary and(or) hypothalamus. Certainly 
further studies are necessary; however, the absence of effects on serum LH in 
two studies (72,83) provides strong evidence for an ovarian effect. Studies in 
rats (89) and mice (90) with low serum ST and delayed puberty also provide 
evidence for gonadal effects of IGF-I. It is of equal importance to elucidate the 
component(s) of the GRF-ST-IGF-I axis that mediates GRFi effects on 
ovarian function. The wealth of information with regard to effects of IGF-I on 
granulosa cell function (35-37) leads to strong speculation that IGF-I is an 
important mediator. IGF-I may have direct effects at the ovary through 
paracrine, autocrine or endocrine effects. Somatotropin may be involved, 
certainly via alteration of serum IGF-I, but also via effects on the ovary. 
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Determination of effects of GRFi on tissue (hypothalamus or ovarian) 
expression of putative signals such as IGF-I , IGFBP-2, -3, -4- and(or) -5 is 
necessary to begin to elucidate this mechanism. 
In conclusion, active immunization against GRF (through associated 
changes in ST, IGF-I, and(or) insulin) results in aberrations in follicular 
growth, possibly mediated through alteration in follicular IGF-I and(or) 
IGFBP. However, a direct effect of GRFi on ovarian GRF cannot be 
excluded. Clearly, GRFi at 3 mo of age altered follicular growth culminating 
in delay in normal timing of estrus. Future studies will be required to better 
elucidate the site through which lowered IGF-I , ST and(or) GRF alter 
follicular growth, ultimately delaying puberty. These data indicate that 
follicular growth and associated endocrine events from 3 to 6 mo of age are 
critically important for normal onset of puberty. 
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